Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Cancer research and Cetuximab, with related work in Head and neck squamous-cell carcinoma, Immunotherapy, KRAS. Notable publications include 'Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors', 'Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy', and 'Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells'.
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma
Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells
The TGFβ–miR200–MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors